Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
CellCept Drug Details
Astrocytes in multiple sclerosis.
Olfactory dysfunction in patients with multiple sclerosis.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Histamine and Immune Biomarkers in CNS Disorders.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Preferential Use of Public TCR during Autoimmune Encephalomyelitis.
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
MS research gears up for new drugs
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Pediatric Optic Neuritis Prospective Outcomes Study.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.
Defining the clinical course of multiple sclerosis: The 2013 revisions.